Dr. Reddy’s Signs Licensing Deal with Gilead to Commercialise HIV Drug, Shares Trading Flat
Shares of Dr. Reddy’s Laboratories Ltd. are trading flat after touching a day’s high of Rs 6,795 on 3rd October. This follows the firm’s announcement...
Download Unicorn Signals App
Powered By EquityPandit
